First-in-Human trial tests new device to fix dangerous artery bulges
NCT ID NCT07005141
Summary
This is the first study in people to test the safety and performance of a new stent-graft device called iHub. It is designed to treat bulges (aneurysms) in the iliac arteries using a minimally invasive procedure. The goal is to seal off the aneurysm while keeping important nearby blood vessels open. Ten adult patients will receive the implant and be followed for one year to see how they do.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM, ABDOMINAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Baía Sul S/A
Florianópolis, Santa Catarina, 88020210, Brazil
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - HCFMUSP
São Paulo, São Paulo, 05403-000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.